Jayma Bio Innovations
Turning brochure style science websites into
product led platforms people trust.

Overview
Jayma Bio Innovations and Sap Symphony needed websites that could communicate complex scientific ideas, showcase products, and establish credibility with their audiences. The challenge was to move beyond conventional informational pages and create product led digital experiences that make bio innovation easier to understand and explore.
I redesigned both websites around clearer product hierarchies, structured storytelling, and stronger visual communication. The work connected scientific credibility with product discovery, helping visitors understand what was being built, why it mattered, and where to go next.

The Problem
The existing websites felt fragmented and brochure like. Important information about the company, its products, research, and broader vision competed for attention, making it difficult for visitors to understand the value of the work quickly.
For audiences such as researchers, institutions, and investors, credibility and clarity are essential. Visitors needed to understand the science, distinguish between products, and find relevant information without navigating disconnected pages or interpreting dense blocks of content.

The Approach
I approached the redesign by treating both websites as product communication platforms rather than static company brochures. The focus was on creating a clear narrative, making products easier to discover, and presenting scientific credibility through structured information.
I reworked the visual hierarchy to bring the core proposition, product offerings, and key information into a more intuitive browsing experience. On the Jayma Bio Innovations website, the structure communicates the company's mission, founder story, innovation journey, and research collaborations. For Sap Symphony, the experience places greater emphasis on product discovery, individual product pages, benefits, and related products.
I also incorporated credibility cues such as Technology Readiness Levels (TRL), research validation, and supporting evidence to help visitors evaluate the work. Consistent interface patterns, product cards, navigation, and conversion points created a more cohesive experience across both websites.

The Results
- A clearer presentation of the company, its scientific work, and its product offerings
- Improved visibility of research validation and credibility signals
- More structured product discovery across wellness, environmental, and technology offerings
- A reusable design direction for future product launches, website updates, and investor communication

What I'd Do Differently
I'd speak directly with more researchers and investors before finalising the content hierarchy. Much of the audience insight came through the internal team, and first hand conversations would have helped identify which scientific details, validation signals, and product claims mattered most to each audience.
I'd also establish the shared content architecture for Jayma Bio Innovations and Sap Symphony earlier. Defining common patterns for product information, credibility markers, navigation, and conversion flows at the beginning would have made the relationship between the two websites more consistent and reduced repeated design decisions.
What I Learned
Science needs a story. Strong research does not automatically translate into clear communication. The order in which information is presented, the hierarchy of the content, and the way products are introduced determine whether visitors can understand the work quickly.
Credibility should be visible. For science driven businesses, trust depends on more than polished visuals. Research validation, Technology Readiness Levels, and clearly presented supporting evidence help visitors assess the maturity and relevance of an innovation.
Product led experiences create clearer next steps. Leading with what is being developed, who it serves, and how to explore it gives visitors a more useful path than presenting company information without a clear connection to its products.
